NCT02414919View on ClinicalTrials.gov

Duration of Use of Highly Effective Reversible Contraception

CompletedOBSERVATIONAL
Enrollment

13,880

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

March 28, 2016

Study Completion Date

March 28, 2016

Conditions
Pregnancy
Interventions
DRUG

Mirena (Levonorgestrel IUS, BAY86-5028)

Levonorgestrel-releasing intrauterine device 20 mcg/day

DRUG

ParaGard

Copper T380A

DRUG

Implanon/Nexplanon

Etonorgestrel contraceptive implant

Trial Locations (1)

Unknown

Salt Lake City

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

University of Utah

OTHER

lead

Bayer

INDUSTRY